Speaker Details

Mitchel Paul Goldman, MD, FAAD

Mitchel Paul Goldman, MD, FAAD

SESSIONS

C002 Live Demonstration: The State of The Art of Aesthetic Dermatology
Mar 8, 2024 • 9:00 AM - 12:00 PM • Room 6A
U047 Medical Problems with Cosmetic Overtones
Mar 9, 2024 • 4:30 PM - 5:30 PM • Room 29D
F077 Veins and Beyond
Mar 10, 2024 • 1:00 PM - 3:00 PM • Room 25B

DISCLOSURES

Accure, Inc – Stockholder(Stock); Acure Acne – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); AVAVA, LLC – Stockholder(Stock); Cannabiomed – Stockholder(Stock); Cell Research Corp – Advisory Board(Stock); Colorescience – Stockholder(Stock); DeepRobotics – Advisory Board(Stock); Dyve Biosciences – Stockholder(Stock); Galderma USA – Investigator(Grants/Research Funding); Lumenis – Investigator(Equipment); MatriSys Bioscience – Stockholder(Stock); Merz Aesthetics – Investigator(Grants/Research Funding); POMEGA, Inc – Advisory Board(Stock); SkinCeauticals LLC – Consultant(Fees); SkinMedica, Inc. – Consultant(Honoraria); SkinMedica, Inc. – Investigator(Grants/Research Funding); Sofwave – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Solta Medical – Investigator(Grants/Research Funding);